太平洋醫材股份有限公司 Approved
最後更新時間 2025/05/12 , 02:23 AM
最後更新時間 2025/05/12 , 02:23 AM
負責人
Zhong,An-Ting
統一編號
20765714
成立日期
1977/08/06
資本額
NT$1,000,000,000
實收資本額
NT$726,000,000
股票代號
4126
電話
037-987979
地址
No. 8, Tongke 2nd Rd., Jiuhu Vil., Tongluo Township, Miaoli County, 366, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zhong,An-Ting Chairman 6.49%
Hong,Zhong-Kai Director 5.57% YI DE Co., Ltd.
Jiang,Meng-Guang Director 4.48% YI SHENG Co., Ltd.
Zhang,An-Zuo Independent Director 0.00%
Qian,Yao-Zu Independent Director 0.00%
Zhan,Zhi-Jun Independent Director 0.00%
Lin,Meng-Hui Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Pharmaceutical and Medical Goods(457113)
  • Manufacture of Measuring, Navigating and Control Equipment(275199)
  • Other Specialized Construction Activities(439099)
  • 公司歷程
  • Change Person in Charge to Zhong,An-Ting
    2020/04/14
  • 員工人數
    財務報表
    項目 2025 2024 2023
    Operating income 604,537 2,345,254 2,320,209
    Operating cost 400,430 1,598,411 1,580,464
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 204,107 746,843 739,745
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 204,107 746,843 739,745
    Operating expenses 71,350 257,070 241,731
    Other gain (loss), net - - -
    Operating profit (loss) 132,757 489,773 498,014
    Non-operating income and expenses 33,142 67,042 27,478
    Net profit (loss) before tax 165,899 556,815 525,492
    Income tax expense (benefits) 33,180 108,969 104,700
    Net profit (loss) of ongoing business for the current period 132,719 447,846 420,792
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 132,719 447,846 420,792
    Other comprehensive profit (loss), net - 9,175 987
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 132,719 457,021 421,779
    Net profit (loss) attributable to owners of parent company - - -
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company - - -
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 1 6 5
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities - - -
    Net cash inflows (outflows) from investing activities - - -
    Net cash inflow (outflow) from financing activities - - -
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period - - -
    Beginning balance of cash and cash equivalents - - -
    Ending balance of cash and cash equivalents - - -
    項目 2025 2024 2023
    Current asset 1,896,668 1,753,993 1,557,643
    Non-current asset 2,102,162 2,127,801 2,210,251
    Total asset 3,998,830 3,881,794 3,767,894
    Current liability 498,407 516,229 514,802
    Non-current liability 425,468 423,339 419,533
    Total liability 923,875 939,568 934,335
    share capital 726,000 726,000 726,000
    Equity - secruity token - - -
    capital reserve 344,801 344,791 344,665
    retained earning 2,004,154 1,871,435 1,762,894
    Other equity 0 0 0
    Treasury stock - - -
    Total equity attributable to owners of parent company - - -
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 3,074,955 2,942,226 2,833,559
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 42 40 39
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    存款不足之退票事宜
    時間 金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • PAHSCO 及設計圖
  • PAHSCO
  • PAHSCO
  • good-flow-MEDICAL-
  • PAHSCO 圖案
  • 太平洋醫材
  • PACO-FUSOR
  • GFM
  • VAC-PROTECTOR
  • PRO FLOW
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Return deposit
    2006
  • Motion of objection
    2019
  • Collection of legal expenses
    2019
  • Confirmation of the existence of employment relationship, etc
    2019
  • Others
    2002, 2008
  • Payment order
    2007, 2008
  • Return payment
    2007
  • Breach of trust
    2011
  • Commit to trial
    2011
  • Fulfill contract
    2007, 2008
  • Pay for the project
    2002, 2006, 2010
  • Return security deposit
    2008
  • Pay contract remuneration, etc.
    2013
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。